These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 32556219

  • 1. Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever.
    Ugurlu S, Ergezen B, Egeli BH, Selvi O, Ozdogan H.
    Rheumatology (Oxford); 2020 Dec 01; 59(12):3892-3899. PubMed ID: 32556219
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö, Kucuk H, Babaoglu H, Guven SC, Ozturk MA, Haznedaroglu S, Goker B, Tufan A.
    Mod Rheumatol; 2019 Mar 01; 29(2):363-366. PubMed ID: 29578360
    [Abstract] [Full Text] [Related]

  • 3. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A, Derin ME, Albayrak F, Karakaş B, Karagöz Y.
    Adv Rheumatol; 2020 Jan 30; 60(1):12. PubMed ID: 32000860
    [Abstract] [Full Text] [Related]

  • 4. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.
    Özçakar ZB, Özdel S, Yılmaz S, Kurt-Şükür ED, Ekim M, Yalçınkaya F.
    Clin Rheumatol; 2016 Feb 30; 35(2):441-6. PubMed ID: 25213327
    [Abstract] [Full Text] [Related]

  • 5. Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.
    Sargin G, Kose R, Senturk T.
    Sao Paulo Med J; 2019 May 08; 137(1):39-44. PubMed ID: 31116269
    [Abstract] [Full Text] [Related]

  • 6. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T, Aydın F, Nilüfer Tekgöz P, Sezer M, Uncu N, Çelikel Acar B.
    Int J Rheum Dis; 2020 Jul 08; 23(7):977-981. PubMed ID: 32558310
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of Canakinumab Treatment in Recipients of Kidney Transplant With Familial Mediterranean Fever: A Case Series.
    Sendogan DO, Saritas H, Kumru G, Eyupoglu S, Sadioglu RE, Tuzuner A, Sengul S, Keven K.
    Transplant Proc; 2019 Sep 08; 51(7):2292-2294. PubMed ID: 31400972
    [Abstract] [Full Text] [Related]

  • 8. Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever.
    Ugurlu S, Hacioglu A, Adibnia Y, Hamuryudan V, Ozdogan H.
    Orphanet J Rare Dis; 2017 May 30; 12(1):105. PubMed ID: 28558744
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure.
    Stankovic Stojanovic K, Delmas Y, Torres PU, Peltier J, Pelle G, Jéru I, Colombat M, Grateau G.
    Nephrol Dial Transplant; 2012 May 30; 27(5):1898-901. PubMed ID: 21931121
    [Abstract] [Full Text] [Related]

  • 11. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
    Kucuksahin O, Yildizgoren MT, Ilgen U, Ates A, Kinikli G, Turgay M, Erten S.
    Mod Rheumatol; 2017 Mar 30; 27(2):350-355. PubMed ID: 27328763
    [Abstract] [Full Text] [Related]

  • 12. A systematic literature review of efficacy, effectiveness and safety of biologic therapies for treatment of familial Mediterranean fever.
    Kuemmerle-Deschner JB, Gautam R, George AT, Raza S, Lomax KG, Hur P.
    Rheumatology (Oxford); 2020 Oct 01; 59(10):2711-2724. PubMed ID: 32533192
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease.
    Bilginer Y, Ayaz NA, Ozen S.
    Clin Rheumatol; 2010 Feb 01; 29(2):209-10. PubMed ID: 19774408
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever.
    Hamanoue S, Suwabe T, Hoshino J, Sumida K, Mise K, Hayami N, Sawa N, Takaichi K, Fujii T, Ohashi K, Yazaki M, Ikeda S, Ubara Y.
    Mod Rheumatol; 2016 Jul 01; 26(4):610-3. PubMed ID: 25619282
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anakinra induces complete remission of nephrotic syndrome in a patient with familial mediterranean fever and amyloidosis.
    Sevillano ÁM, Hernandez E, Gonzalez E, Mateo I, Gutierrez E, Morales E, Praga M.
    Nefrologia; 2016 Jul 01; 36(1):63-6. PubMed ID: 26409501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.